Kazan Federal University Digital Repository

Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial

Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial

Gaysina Leylya Rafaelevna; Bain Stephen; Bode Bruce; Clausen Jesper Ole; Coppieters Ken; Gumprecht Janusz; Hansen Troels Krarup; von Herrath Matthias; Mathieu Chantal; Morales Cristobal; Mosenzon Ofri; Segel Stine; Tsoukas George; Pieber Thomas R
URI: https://dspace.kpfu.ru/xmlui/handle/net/163520
Date: 2021

Show full item record

Files in this item

Icon Blocked войти
Size: 517.8Kb
Format: PDF
Доступ к контенту ограничен

This item appears in the following Collection(s)

Search DSpace


Advanced Search

Browse

My Account

Statistics